Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo attack on liver tumors shows promise for advanced colorectal cancer

NCT ID NCT04595266

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study tests whether adding a targeted chemotherapy directly into the liver (via tiny beads) to standard全身化疗 can better shrink tumors in people with colorectal cancer that has spread only to the liver and has a poor outlook. About 48 adults will be randomly assigned to receive either standard chemo alone or standard chemo plus the liver-directed treatment. The main goal is to see how many patients have significant tumor shrinkage after 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Complejo Hospitalario de Navarra

    Pamplona, Pamplona, Spain

  • H. Univ. Ramón y Cajal

    Madrid, Madrid, 28044, Spain

  • Hospital Clínic

    Barcelona, Barcelona, Spain

  • Hospital Parc Taulí

    Sabadell, Barcelona, Spain

  • Hospital Universitari i Politècnic La Fe

    Valencia, Valencia, 46026, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain

  • Hospital Universitario La Paz

    Madrid, Madrid, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Barcelona, Spain

Conditions

Explore the condition pages connected to this study.